deltatrials
Unknown PHASE2 NCT01668264

Imaging Assessment of Diastolic Function

Combined Echocardiographic and MRI Assessment of Diastolic Function in Patients With Congenital Heart Disease

Sponsor: The Hospital for Sick Children

Updated 6 times since 2017 Last updated: Jun 22, 2016

This PHASE2 trial investigates Congenital Heart Disease and is currently ongoing. The Hospital for Sick Children leads this study, which shows 6 recorded versions since 2026 — indicating limited longitudinal coverage. Heart and vascular conditions benefit from the kind of long-term tracking this trial provides.

Change History

6 versions recorded
  1. Sep 2024 — Present [monthly]

    Unknown PHASE2

  2. Jul 2024 — Sep 2024 [monthly]

    Unknown PHASE2

    Status: Unknown StatusUnknown

  3. Jan 2021 — Jul 2024 [monthly]

    Unknown Status PHASE2

  4. Jul 2018 — Jan 2021 [monthly]

    Unknown Status PHASE2

    Status: Not Yet RecruitingUnknown Status

  5. Jun 2018 — Jul 2018 [monthly]

    Not Yet Recruiting PHASE2

Show 1 earlier version
  1. Jan 2017 — Jun 2018 [monthly]

    Not Yet Recruiting PHASE2

    First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • The Hospital for Sick Children
Data source: The Hospital for Sick Children

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

  • Toronto, Canada